Lycia Therapeutics: 10% owner Staben Steven received 110,896 shares

What happened

• The filing says Staben Steven, a 10% owner, received a grant of derivative securities covering 110,896 shares on Aug 11, 2026 at $0.00 per share, total $0.

Key details

• Transaction date and price: Aug 11, 2026; $0.00 per share.
• Transaction type: Award/Grant (code A); reported as a derivative (options).
• Vesting: options vest 1/48 of the total award monthly over 4 years, with the first tranche vested on Sep 6, 2026, subject to continued service (footnote F2).
• Reporting note: the transaction occurred prior to the issuer's registration of a class of equity securities and is reported pursuant to Rule 16a-2(a) (footnote F1).
• Shares owned after the transaction: not stated in the filing.

Why it may matter

• This was an option award (derivative), not a public market purchase or sale; the shares are subject to vesting.
• The reporting person is a 10% owner, which is a large holder category under SEC rules.
• A filing does not show why the insider traded or why the company acted.